Growth Metrics

Acro Biomedical (ACBM) Receivables - Other (2019)

Acro Biomedical's quarterly Receivables - Other came in at $45000.0 in Q3 2019, up 125.0% quarter-over-quarter from $20000.0 in Q2 2019.

Acro Biomedical has reported Receivables - Other for 1 years, with the latest figure at $45000.0 in Q3 2019.

  • For the quarter ending Q3 2019, Receivables - Other changed N/A year-over-year to $45000.0; the trailing twelve-month figure through Sep 2019 stood at $45000.0 (changed N/A YoY), and the FY2019 full-year result was $45000.0, changed N/A from the prior year.
  • Receivables - Other for Q3 2019 stood at $45000.0, up from $20000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $45000.0 in Q3 2019, with the low at $20000.0 in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn -
2 Berto Acquisition 316.66 Mn 316.66 Mn -
3 Centurion Acquisition 311.94 Mn 311.94 Mn -
4 Churchill Capital Corp IX 311.36 Mn 311.36 Mn -
5 Agriculture & Natural Solutions Acquisition 301.94 Mn 301.94 Mn -
6 Siddhi Acquisition Corp (Cayman Islands) 286.76 Mn 286.76 Mn -
7 Bold Eagle Acquisition 276.06 Mn 276.06 Mn -
8 Cartesian Growth Corp III 270.68 Mn 270.68 Mn -
9 Oyster Enterprises II Acquisition 266.84 Mn 266.84 Mn -
10 Acro Biomedical - - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2019 45,000.00
Sep 30, 2019 45,000.00
Jun 30, 2019 20,000.00
Jun 30, 2019 20,000.00